NCT05501548 2025-01-29
Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
Clinical Trials
4 trialsNCT02516670 2023-06-07
Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT00270647 2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA Completed
NCT01080352 2015-03-26
Vitamin C as an Anti-cancer Drug
Copenhagen University Hospital at Herlev
Phase 2 Completed